Fresenius Medical Care

Fresenius Medical Care is a German healthcare company that specializes in providing kidney dialysis services globally. Established in 1996, it operates a vast network of outpatient dialysis centers, serving a significant number of patients with end-stage renal disease. The company has a strong presence in the United States, with a 38% market share in the dialysis market. Fresenius Medical Care offers dialysis products and services, therapeutic apheresis products, and has expanded its services through acquisitions like NxStage, a U.S.-based maker of in-home dialysis devices. The company has faced legal challenges, including settling allegations of civil bribery in multiple countries. Notably, in March 2023, it received certification for its compliance program related to the U.S. Foreign Corrupt Practices Act. Fresenius Medical Care is a key player in the healthcare industry, focusing on research, innovation, and compassionate patient care.